STOKEASO-2

N/A

Report date: 2025/04/11 15:09:47
NME

Base Information

Drug NameSTOKEASO-2
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRas/Rap GTPase-activating protein SynGAP stimulants
TargetsRas/Rap GTPase-activating protein SynGAP
Therapy Area/IndicationsNeurodevelopmental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStoke Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcadia Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A